| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2025 | Jul 2, 2025 | Athira Pharma, Inc. | CHIEF SCIENTIFIC OFFICER | Sell | 60.0 | +1,474 | 0.48% | ✗ | $2.5K |
| Nov 18, 2024 | Jan 3, 2025 | Athira Pharma, Inc. | CHIEF SCIENTIFIC OFFICER | Sell | 67.5 | +1,410 | 0.61% | ✗ | $4.8K |
| May 20, 2024 | Sep 5, 2024 | Athira Pharma, Inc. | CHIEF SCIENTIFIC OFFICER | Sell | 90.0 | +12,428 | 15.49% | ✗ | $1.4K |
| May 18, 2023 | Feb 16, 2024 | Athira Pharma, Inc. | CHIEF SCIENTIFIC OFFICER | Sell | 90.0 | +11,794 | 17.23% | ✗ | $7K |
| May 18, 2023 | Jan 8, 2024 | Athira Pharma, Inc. | Chief Scientific Officer | Sell | 82.5 | +11,794 | 4.02% | ✗ | $7K |
| Jun 22, 2022 | Jun 24, 2022 | Athira Pharma, Inc. | Executive VP, Research | Sell | 90.0 | +7,386 | 14.68% | ✗ | $7K |